Genomics

Dataset Information

0

Genome-wide gene expression of HML58-3 (a derivative cell line of HCT116) after treatment of DAC (decitabine), OR-2003, and OR-2100

ABSTRACT: A derivative cell line of HCT116, HML58-3, was established to detect DNA demethylating agents [Okochi-Takada E, Epigenetics. 2018;13:147-55.]. HML58-3 cells were treated with DNA demethylating agents (decitabine, OR-2003, and OR-2100) or mock. A genome-wide gene expression analysis was performed using SurePrint G3 Human Gene Expression 8 x 60K v2 Microarray.

ORGANISM(S): Homo sapiens

PROVIDER: GSE134294 | GEO | 2019/08/01

REPOSITORIES: GEO

Json Xml

Similar Datasets

Methylation profiling Genome-wide DNA demethylation of HML58-3 (a derivative cell line of HCT116) after treatment of DAC, OR-2003, and OR-2100
2019-08-01 | GSE134293 | GEO
Transcriptomics Genome-wide gene expression of NB-1 after treatment of 5-aza-dC, TBT, and combination
2021-07-23 | GSE180645 | GEO
Transcriptomics Gene expression profile of K562 and KBM5 treated with the combination of imatinib and a new demethylating agent, OR-2100
2020-09-09 | GSE157620 | GEO
Transcriptomics The impact of decitabine treatment in MDS-induced Tet2KD/KDEzh2Δ/Δ LSK HSPCs
2017-03-15 | GSE79204 | GEO
Genomics microRNA expression profiling of paired primary and lymph node metastatic breast cancer patients
2020-05-31 | GSE148846 | GEO
Genomics Agilent SurePrint G3 Mouse GE V2.0 Microarray(8*60K,Design ID:074809)
| PRJNA699158 | ENA
Genomics Genome-wide gene expression of HML58-3 (a derivative cell line of HCT116) after treatment of DAC (decitabine), OR-2003, and OR-2100
| PRJNA554657 | ENA
Transcriptomics gene expression of KYSE510 cells with treatment of 100 nM PAF for 24 hours
2023-12-16 | GSE163355 | GEO
Transcriptomics Gene expression of KYSE410 cells with treatment of 10 uM FAK inhibitor (defactinib) for 4 hours and 24 hours
2022-07-07 | GSE155591 | GEO
Transcriptomics SMARCA4 reads PRMT1-mediated H4R3me2a to promote colorectal cancer progression II
2020-01-07 | GSE143199 | GEO